Clinical Trial Update: Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating thalidomide in combination with concurrent chemoradiotherapy for esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Changzhou No.2 People's Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN